Heghine Khachatryan: New Evidence in Perioperative Hemostasis – Clinical Value of Perioperative TXA Use in General Surgery
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared a post by JAMA Surgery on LinkedIn:
“New Evidence in Perioperative Hemostasis
A newly published systematic review and meta-analysis in JAMA Surgery highlights the clinical value of perioperative tranexamic acid (TXA) use in general surgery.
Key findings:
- Significant reduction in intraoperative blood loss
- Decreased transfusion requirements
- Lower incidence of major bleeding
- No observed increase in thromboembolic events
These data further support TXA as an effective and safe component of modern blood management strategies when used appropriately and with proper patient selection.
For hematologists, surgeons, anesthesiologists, and perioperative teams, this reinforces the importance of evidence-based antifibrinolytic use as part of multidisciplinary bleeding control and patient blood management (PBM) programs.
Perioperative Use of Tranexamic Acid in General Surgery: A Systematic Review and Meta-Analysis
Published online: December 17, 2025 | JAMA Surgery
A meaningful step toward safer surgery, fewer transfusions, and better outcomes.”
Quoting JAMA Surgery’s post:
“Systematic review and meta-analysis: Prophylactic TXA use was associated with lower intraoperative blood loss, transfusion requirements, and major bleeding without an observed increase in thromboembolic or mortality risk.”
Title: Perioperative Use of Tranexamic Acid in General Surgery: A Systematic Review and Meta-Analysis
Authors: Lucas Monteiro Delgado, Bernardo Fontel Pompeu, Gabriel Henrique Acedo Martins, Mariana Lima Azevedo, Eric Pasqualotto, Thiago Celestino Chulam, Sérgio Mazzola Poli de Figueiredo
Read the full article here.
Stay updated and find more posts featuring Heghine Khachatryan on Hemostasis Today.
-
Oct 15, 2026, 16:26Hauke Horstmann: Can an Existing Drug Be Repurposed to Treat Atherosclerosis?
-
Oct 15, 2026, 15:19Bernadette Borrelli: AdventHealth Teams Unite to Mark World Thrombosis Day
-
Oct 15, 2026, 15:03Mohamed Magdy: The Hematological Consequences of Portal Hypertension in Banti Syndrome
-
Oct 15, 2026, 14:34Marium Khan: New Systematic Review Examines Asundexian Safety and Efficacy in Cardiovascular Disease
-
Oct 15, 2026, 14:03JTH Research Recap Explores Occult Malignancy Screening in DVT
-
Oct 15, 2026, 13:52Thierry Peyrard: A Heartfelt Thank You Ahead of Blood 2026
-
Oct 15, 2026, 12:40Todd Keitz: DVT and PE Explained in Five Minutes
-
Oct 15, 2026, 12:35Bartosz Hudzik: Balancing Ischemic and Bleeding Risk After ACS and PCI
-
Oct 15, 2026, 12:25Violeta Jardin: Understanding Fibrinolytic Shutdown Beyond Conventional TEG